RCE in Brivo Acs100
CVE-2023-6260
Improper Neutralization of Special Elements used in an OS Command ('OS Command Injection') vulnerability in Brivo ACS100, ACS300 allows OS Command Injection, Bypassing Physical Security.This issue affects ACS100 (Network Adjacent Access), ACS300 (Physical Access): from 5.2.4 before 6.2.4.3.
Vulnerability class: Command Injection (OS Command Injection)
EPSS: 0.009 (56.1th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 9.0 (Critical). Vector: CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H.
Affected products
Weakness classification (CWE)
Public proof-of-concept exploits
References
- 57dba5dd-1a03-47f6-8b36-e84e47d335d8 (Third Party Advisory)
- 57dba5dd-1a03-47f6-8b36-e84e47d335d8 (Release Notes)
Frequently asked questions
- What is CVE-2023-6260?
- CVE-2023-6260 is a critical-severity vulnerability in Brivo Acs100, classified under OS Command Injection. CVSS score: 9.0/10. Published 2024-02-19.
- How severe is CVE-2023-6260?
- Critical severity. CVSS v3 base score is 9.0 out of 10.
- Is CVE-2023-6260 known to be exploited?
- 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.